Literature DB >> 17952101

A vision of individualized medicine in the context of global health.

D A Cortese1.   

Abstract

The Three Musketeers' slogan of solidarity-"All for one, and one for all"-aptly describes how the emerging science of individualized medicine (IM) promises to transform the value of the medical care we deliver to specific individuals as well as global populations.

Mesh：

Year:  2007        PMID： 17952101     DOI： 10.1038/sj.clpt.6100390

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  23 in total

1.  The roadmap to personalized medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

2.  Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

3.  Clinical and translational sciences: at the intersection of molecular and individualized medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

4.  Translational medicine in the era of health care reform.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

5.  Experimental therapeutics: a paradigm for personalized medicine.

Authors:  Scott A Waldman; Walter K Kraft; Timothy J Nelson; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

6.  The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions.

Authors:  Mehmet U S Ayvaci; Oguzhan Alagoz; Elizabeth S Burnside
Journal:  Manuf Serv Oper Manag       Date:  2012-04       Impact factor: 7.600

7.  Bionic technologies transforming the science of healthcare delivery.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2011-04       Impact factor: 4.689

Review 8.  The emerging role of metabolomics in the development of biomarkers for pulmonary hypertension and other cardiovascular diseases (2013 Grover Conference series).

Authors:  Gregory D Lewis
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

Review 9.  Early identification of cardiovascular risk using genomics and proteomics.

Authors:  Iftikhar J Kullo; Leslie T Cooper
Journal:  Nat Rev Cardiol       Date:  2010-05-04       Impact factor: 32.419

Review 10.  Genetics of ischemic stroke: inheritance of a sporadic disorder.

Authors:  Owen A Ross; James F Meschia
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.